Associated Papers
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.
Tosco A et al.
Cell Death and Differentiation, 2016
Select a paper to view details